Image_1_Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis.pdf
Objective: Obesity is a risk factor for Rheumatoid Arthritis (RA) being associated to low grade inflammation. This study aimed to determine whether PEDF and Chemerin are biomarkers of inflammation related to fat accumulation in RA and to investigate whether weight loss associates with clinical disease improvement through the modification of fat-related biomarkers in overweight/obese RA with low-moderate disease.
Participants and Methods: Two-hundred and thirty RA patients were enrolled, of whom 176 at disease onset treated according to a treat-to-target strategy (T2T) and 54 overweight/obese RA in stable therapy and low-moderate disease activity. Gene expression of adipokines, interleukin-6 and their receptors were examined in adipose tissue from obese RA. Obese RA with low-moderate disease activity underwent low-calories diet aiming to Body Mass Index (BMI) reduction >5%, maintaining RA therapy unchanged. Chemerin, PEDF and Interleukin-6 plasma values were assessed by ELISA and disease activity was evaluated.
Results: At RA onset, PEDF and Chemerin plasma values correlated with BMI (p < 0.001) but only Chemerin plasma values correlated with disease activity (p < 0.001). After adopting a T2T strategy, Chemerin arose as an independent factor associated with remission in early RA [OR(95%CIs):0.49(0.25–0.97)]. Moreover, after low-calories diet, RA with low-moderate disease activity reaching BMI reduction ≥5% (62.6%) at 6 months had significant decrease of PEDF (p < 0.05) and Chemerin (p < 0.05) plasma values, in parallel with the improvement in disease activity.
Conclusions: PEDF and Chemerin arose as biomarkers of obesity and metaflammation respectively, providing a link between chronic inflammation and excess of body weight in RA. Therefore, BMI reduction of at least 5% in obese RA allowed better disease control without modifying RA treatment.
History
References
- https://doi.org//10.1016/S0140-6736(11)60813-1
- https://doi.org//10.1586/1744666X.2016.1159132
- https://doi.org//10.1186/s13075-015-0601-x
- https://doi.org//10.1186/ar2383
- https://doi.org//10.1016/j.trsl.2016.01.002
- https://doi.org//10.1002/art.30136
- https://doi.org//10.1002/acr.21768
- https://doi.org//10.1038/ijo.2010.212
- https://doi.org//10.1210/jc.2010-0630
- https://doi.org//10.1530/EJE-08-0521
- https://doi.org//10.2119/molmed.2012.00156
- https://doi.org//10.1210/en.2007-0175
- https://doi.org//10.1210/jc.2009-2374
- https://doi.org//10.1016/j.yexmp.2011.10.006
- https://doi.org//10.1186/ar3475
- https://doi.org//10.1016/j.jbspin.2013.07.013
- https://doi.org//10.1002/acr.22932
- https://doi.org//10.1093/rheumatology/key066
- https://doi.org//10.1002/art.27584
- https://doi.org//10.1136/annrheumdis-2012-201456
- https://doi.org//10.1136/annrheumdis-2015-207524
- https://doi.org//10.1056/NEJMoa0708681
- https://doi.org//10.1111/obr.12241
- https://doi.org//10.1007/s40273-014-0230-2
- https://doi.org//10.1016/j.autrev.2011.04.018
- https://doi.org//10.1186/ar3273
- https://doi.org//10.1016/j.jacc.2013.11.004
- https://doi.org//10.1016/j.cmet.2015.02.006
- https://doi.org//10.1371/journal.pone.0133494
- https://doi.org//10.3899/jrheum.150224
- https://doi.org//10.1186/s13075-016-1146-3
- https://doi.org//10.1155/2018/4670521
- https://doi.org//10.2119/molmed.2010.00067
- https://doi.org//10.1111/j.1742-4658.2008.06580.x
- https://doi.org//10.1038/447525a
- https://doi.org//10.1158/1940-6207.CAPR-10-0381
- https://doi.org//10.1073/pnas.0904412106
- https://doi.org//10.1186/s13075-017-1308-y
- https://doi.org//10.1074/jbc.M110.123620
- https://doi.org//10.1136/annrheumdis-2016-209206
Usage metrics
Read the peer-reviewed publication
Categories
- Radiology and Organ Imaging
- Foetal Development and Medicine
- Obstetrics and Gynaecology
- Medical Genetics (excl. Cancer Genetics)
- Medical and Health Sciences not elsewhere classified
- Dermatology
- Emergency Medicine
- Gastroenterology and Hepatology
- Geriatrics and Gerontology
- Intensive Care
- Primary Health Care
- Nephrology and Urology
- Nuclear Medicine
- Orthopaedics
- Otorhinolaryngology
- Pathology (excl. Oral Pathology)
- Family Care